Noriaki Kume

Title: Noriaki Kume: Innovator in Monoclonal Antibody Development

Introduction

Noriaki Kume is a distinguished inventor based in Kyoto, Japan. He is recognized for his significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His innovative work has the potential to impact medical research and therapeutic applications.

Latest Patents

Noriaki Kume holds a patent for a monoclonal antibody to soluble LOX-1. This invention aims to provide a monoclonal antibody that specifically recognizes human soluble LOX-1, with a dissociation constant (Kd) for human soluble LOX-1 of 1×10(M) or less. The antibody is produced from a hybridoma prepared through a series of meticulous steps, including immunizing a non-human animal, collecting antibody-producing cells, fusing these cells with myeloma cells, and selecting hybridomas that produce the desired monoclonal antibody.

Career Highlights

Kume is currently associated with Shionogi Company Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and excellence in the field of biotechnology.

Collaborations

Some of his notable coworkers include Goro Kominami and Masahiro Nakamura, who have collaborated with him on various projects within the company.

Conclusion

Noriaki Kume's contributions to the development of monoclonal antibodies exemplify the spirit of innovation in biotechnology. His work not only enhances our understanding of human health but also paves the way for future advancements in medical treatments.